Try
Progyny, Inc.
PGNYUnited States
55 filed reports · 395 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
55 reports · Sep 2019 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 399 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 27 | 409 | Sep 2019 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 21 | 2,329 | Sep 2019 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 7 | 3,256 | Dec 2019 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 7, 2026 | 282 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 22 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 8, 2026 | 201 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 7, 2026 | 12 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 27, 2026 | 843 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 26, 2026 | 24 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 7, 2025 | 171 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 16 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 8, 2025 | 112 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 12 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 9, 2025 | 112 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 8, 2025 | 20 | Open |
Financial data
395 concepts · 5,994 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial379 concepts · 5,406 facts · Dec 2017 to Jul 2026
- Cost of goods and services sold (US GAAP)43 · Dec 2017 to Jun 2026
- General and administrative expense (US GAAP)43 · Dec 2017 to Jun 2026
- Gross profit (US GAAP)43 · Dec 2017 to Jun 2026
- Income tax expense benefit43 · Dec 2017 to Jun 2026
- Net income loss43 · Dec 2017 to Jun 2026
- Operating expenses (US GAAP)43 · Dec 2017 to Jun 2026
- Operating income loss43 · Dec 2017 to Jun 2026
- Revenue43 · Dec 2017 to Jun 2026
- Selling and marketing expense (US GAAP)43 · Dec 2017 to Jun 2026
- Stockholders equity (US GAAP)43 · Dec 2017 to Jun 2026
- Net income loss available to common stockholders basic42 · Dec 2017 to Jun 2026
- Comprehensive income net of tax41 · Dec 2017 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value40 · Sep 2018 to Jun 2026
- Allocated share based compensation expense40 · Sep 2018 to Jun 2026
- Depreciation depletion and amortization40 · Dec 2017 to Jun 2026
- Increase decrease in accounts payable40 · Dec 2017 to Jun 2026
- Increase decrease in accounts receivable40 · Dec 2017 to Jun 2026
- Increase decrease in accrued liabilities and other operating liabilities40 · Dec 2017 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets40 · Dec 2017 to Jun 2026
- Net cash provided by used in financing activities40 · Dec 2017 to Jun 2026
- Net cash provided by used in investing activities40 · Dec 2017 to Jun 2026
- Net cash provided by used in operating activities40 · Dec 2017 to Jun 2026
- Net income loss available to common stockholders diluted40 · Dec 2017 to Jun 2026
- Payments to acquire property plant and equipment40 · Dec 2017 to Jun 2026
Guidance7 concepts · 409 facts · Dec 2019 to Aug 2026
- Revenue Guidance109 · Dec 2019 to Aug 2026
- EPS (Diluted) Guidance108 · Dec 2019 to Aug 2026
- Net Income Guidance108 · Dec 2019 to Aug 2026
- Revenue Growth Guidance58 · Feb 2021 to Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))20 · May 2024 to Aug 2026
- Revenue Growth Guidance (excluding the $48.5 million of revenue in 2025 from the large client who was under a transition agreement in the first half of 2025)4 · Feb 2026 to Aug 2026
- Revenue Growth Guidance (excluding the $31.3 million of revenue in 2025 from the large client under a transition agreement)2 · Feb 2026
Segment8 concepts · 99 facts · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- General and administrative expense (US GAAP)14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Interest income other14 · Dec 2022 to Jun 2026
- Net income loss attributable to noncontrolling interest14 · Dec 2022 to Jun 2026
- Reportable segment14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Total Assets1 · Mar 2024
Product1 concepts · 80 facts · Sep 2018 to Jun 2026
- Revenue80 · Sep 2018 to Jun 2026
Segments
179 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments2 members · 99 facts
- Reportable98 · Dec 2022 to Jun 2026
- Reportable segment1 · Mar 2024
Product or service2 members · 80 facts
- Fertility Benefit Services40 · Sep 2018 to Jun 2026
- Pharmacy Benefit Services40 · Sep 2018 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.